Adage Capital Partners Gp, L.L.C. T2 Biosystems, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$1.47 - $3.16 $588,000 - $1.26 Million	-400,000 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$2.98 - $6.86 $596,000 - $1.37 Million	200,000 Added 100.0%	400,000 $1.2 Million
Q3 2018 Nov 14, 2018	BUY	$5.36 - $7.83 $1.07 Million - $1.57 Million	200,000 New	200,000 $1.49 Million
Q4 2017 Feb 14, 2018	SELL	$3.73 - $4.6 $373,000 - $459,999	-100,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$3.9 - $6.78 $390,000 - $678,000	100,000	100,000 $420,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $15.9M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.